Wockhardt Ltd

₹ 1,311 -1.04%

21 Nov - close price

wockhardt.com BSE: 532300 NSE: WOCKPHARMA

About

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments). ^[1]

Key Points

Market Position
The company is amongst the top 3 Indian generic companies in the UK and the 6th largest generic supplier in the retail and hospital channels in Ireland. It is the No. 1 Methycobalamin brand in India. ^[1]

Website BSE NSE

Market Cap ₹ 21,311 Cr.
Current Price ₹ 1,311
High / Low ₹ 1,870 / 1,110
Stock P/E 388
Book Value ₹ 281
Dividend Yield 0.00 %
ROCE 3.75 %
ROE -1.22 %
Face Value ₹ 5.00

Add ratio to table

Edit ratios

Pros

Cons

Stock is trading at 4.67 times its book value
Company has low interest coverage ratio.
The company has delivered a poor sales growth of 1.15% over past five years.
Company has a low return on equity of -6.96% over last 3 years.
Promoter holding has decreased over last 3 years: -14.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Pharma Nifty Smallcap 100 Nifty Alpha 50 BSE Allcap BSE SmallCap Select Index BSE 250 SmallCap Index BSE 400 MidSmallCap Index Nifty MidSmallcap 400 Nifty Smallcap 50 Nifty Smallcap 250 Nifty 500 Multicap 50:25:25 Nifty Total Market Nifty MidSmall Healthcare Nifty500 Multicap India Manufacturing 50:30:20 Nifty500 Equal Weight

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
	679	699	678	644	753	701	700	739	809	721	743	738	782
	636	654	675	628	681	664	759	648	699	593	679	666	604
Operating Profit	43	45	3	16	72	37	-59	91	110	128	64	72	178
OPM %	6%	6%	0%	2%	10%	5%	-8%	12%	14%	18%	9%	10%	23%
	-138	-1	-64	0	24	8	10	30	9	8	15	-77	21
Interest	70	83	76	79	76	77	73	73	73	60	48	48	55
Depreciation	65	66	56	55	55	55	58	54	55	55	53	56	53
Profit before tax	-230	-105	-193	-118	-35	-87	-180	-6	-9	21	-22	-109	91
Tax %	-10%	-3%	23%	15%	109%	-1%	-2%	167%	78%	5%	105%	-1%	10%
	-207	-102	-237	-136	-73	-86	-177	-16	-16	20	-45	-108	82
EPS in Rs	-13.12	-6.66	-14.44	-9.30	-5.34	-5.76	-11.02	-0.91	-1.43	0.86	-1.54	-5.54	4.80
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	4,830	4,482	4,453	4,015	3,937	3,566	2,844	2,708	3,230	2,651	2,798	3,012	2,984
	3,805	3,772	3,959	4,002	3,935	3,604	2,725	2,771	2,932	2,550	2,707	2,619	2,542
Operating Profit	1,026	709	494	13	2	-38	119	-63	298	101	91	393	442
OPM %	21%	16%	11%	0%	0%	-1%	4%	-2%	9%	4%	3%	13%	15%
	88	67	66	114	-238	116	133	975	-163	-172	17	62	-33
Interest	83	55	129	225	255	265	276	249	299	302	305	254	211
Depreciation	140	145	142	149	150	164	224	246	247	251	223	217	217
Profit before tax	891	575	289	-247	-641	-351	-247	417	-411	-624	-420	-16	-19
Tax %	5%	28%	13%	-9%	4%	-38%	-82%	-65%	-32%	-0%	12%	256%
	843	413	252	-226	-667	-217	-43	689	-279	-621	-472	-57	-51
EPS in Rs	58.91	28.30	17.45	-13.62	-42.30	-13.52	-4.81	47.64	-16.94	-38.80	-30.18	-2.89	-1.42
Dividend Payout %	13%	54%	0%	-56%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	-4%
5 Years:	1%
3 Years:	-2%
TTM:	1%

Compounded Profit Growth
10 Years:	%
5 Years:	11%
3 Years:	15%
TTM:	122%

Stock Price CAGR
10 Years:	-1%
5 Years:	28%
3 Years:	76%
1 Year:	6%

Return on Equity
10 Years:	-2%
5 Years:	0%
3 Years:	-7%
Last Year:	-1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	55	55	55	55	55	55	55	55	72	72	77	81	81
Reserves	3,228	3,362	3,720	3,281	2,797	2,619	2,616	3,321	3,777	3,282	3,282	4,272	4,486
	2,205	2,309	2,677	4,160	3,748	3,375	3,582	2,673	2,198	2,184	2,356	2,021	2,456
	1,134	1,213	1,622	1,486	1,528	1,764	1,894	1,695	2,168	2,113	1,899	1,726	1,510
Total Liabilities	6,622	6,939	8,074	8,982	8,128	7,813	8,148	7,744	8,215	7,651	7,614	8,100	8,533
	2,295	2,123	2,809	2,773	2,888	3,058	3,502	3,343	3,462	3,042	2,881	2,736	4,396
CWIP	708	1,007	1,036	1,244	1,433	1,445	1,585	1,379	1,342	1,539	1,722	2,033	583
Investments	577	341	0	563	214	0	0	0	0	0	0	422	696
	3,043	3,468	4,228	4,403	3,593	3,309	3,060	3,022	3,411	3,070	3,011	2,909	2,858
Total Assets	6,622	6,939	8,074	8,982	8,128	7,813	8,148	7,744	8,215	7,651	7,614	8,100	8,533

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	1,476	355	-42	-269	68	183	649	-287	413	153	219	-22
	-823	-222	-105	-684	635	93	-147	1,471	-204	-118	-138	-780
	-601	-76	193	1,254	-769	-776	-680	-1,171	-71	-315	334	409
Net Cash Flow	52	57	46	301	-66	-500	-178	13	138	-280	415	-393

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	36	60	91	94	89	130	159	124	104	110	81	80
Inventory Days	201	250	249	243	174	183	209	257	222	216	201	234
Days Payable	113	136	144	117	122	187	272	186	265	285	240	191
Cash Conversion Cycle	124	175	196	220	141	126	97	195	60	41	41	123
Working Capital Days	-7	14	52	36	-56	-51	-171	-133	-116	-186	-148	-23
ROCE %	18%	10%	7%	-1%	-1%	-1%	-1%	-3%	1%	-0%	-1%	4%

Shareholding Pattern

Numbers in percentages

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
	60.36%	59.31%	58.40%	55.14%	54.93%	51.60%	51.99%	51.99%	49.09%	49.09%	49.09%	49.09%
	2.87%	2.78%	2.60%	3.03%	4.18%	5.49%	5.94%	6.70%	6.54%	6.82%	7.29%	7.10%
	0.22%	0.22%	0.18%	0.21%	0.30%	4.82%	4.45%	5.08%	9.82%	10.58%	11.00%	11.00%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	0.02%	0.02%	0.02%	0.02%	0.02%
	36.55%	37.70%	38.83%	41.62%	40.59%	38.06%	37.62%	36.21%	34.54%	33.50%	32.60%	32.79%
No. of Shareholders	1,84,908	1,82,493	1,78,915	1,72,989	1,61,813	1,46,138	1,40,391	1,38,142	1,42,710	1,41,799	1,46,918	1,37,946

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
	74.25%	74.11%	74.07%	72.13%	72.12%	67.13%	59.31%	51.60%	49.09%	49.09%
	4.55%	5.45%	4.74%	4.85%	3.10%	2.89%	2.78%	5.49%	6.82%	7.10%
	2.71%	4.99%	2.55%	0.24%	0.09%	0.09%	0.22%	4.82%	10.58%	11.00%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.02%	0.02%
	18.49%	15.45%	18.64%	22.78%	24.69%	29.89%	37.70%	38.06%	33.50%	32.79%
No. of Shareholders	1,24,403	99,736	1,14,338	1,17,324	1,25,488	1,72,460	1,82,493	1,46,138	1,41,799	1,37,946

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Right Issue

Credit ratings

Concalls

Jun 2025
Transcript PPT
Jun 2025

Transcript

Notes
PPT
Feb 2025

Transcript

Notes
PPT
Oct 2024

Transcript

Notes
PPT
Feb 2024

Transcript

Notes
PPT
Feb 2023
Transcript PPT
Mar 2022

Transcript

Notes
PPT